Alandag Celal
- Nouveau
- 17 années d'expérience
- Lieu : Turquie, Sivas
Comparez les meilleurs médecins Cancer du rein et les prix en Turquie. Trouvez votre meilleure correspondance ici.
Nous sélectionnons à la main les meilleurs médecins selon vos besoins et votre budget.
Examiné médicalement par Fahad Mawlood
Éditeur Médical et Scientifique des DonnéesMeilleurs médecins
2
Turquie
Avis
14000+
De vrais patients
Obtenez gratuitement des plans de traitement personnalisés et choisissez la meilleure option. Sans engagement · Aucun paiement pour nos services
Choisir une clinique à l'étranger peut être stressant. Chez Bookimed, avec plus de 800 000 patients aidés, nous comprenons vos préoccupations. Nous savons comment trouver des médecins de confiance, les meilleures options qualité-prix, et des solutions pour les cas les plus complexes. Nous sommes là pour vous guider à chaque étape.
Yan Matsiivskiy
Responsable de l'équipe de coordination médicale
4300++ parcours patients accompagnés
3 années chez Bookimed
278 patients du Turkey ont trouvé leur médecin grâce à nous ce mois-ci
Quiz de 2 minutes
Indiquez-nous votre objectif, budget, délai
Appariement humain + IA
Notre algorithme trouve des correspondances, le coordinateur vérifie l'adéquation
Vos options prêtes
Comparez les prix, forfaits, dates. Discutez avec votre coordinateur
Trop de choix ?
Accompagnement de votre traitement
Coordinateurs médicaux personnels formés






| Classement | Médecin | expérience | Bon choix pour | Ce qui les distingue | Clinique et emplacement | Consultation |
|---|
Turkey is a high-authority destination for kidney cancer care. Turkish medical centers report success rates up to 95% for kidney surgeries. Facilities utilize Da Vinci XI robotic systems and CyberKnife technology. JCI-accredited hospitals provide specialized teams with rapid access to treatment.
Bookimed Expert Insight: Anadolu Medical Center stands out because it employs over 250 specialized oncologists. This massive scale allows for highly specific sub-specialization in rare renal pathologies. Our data shows hospitals with this volume offer more refined tumor board reviews. This multidisciplinary approach is vital for complex stage 3 or 4 cases.
Patient Consensus: Patients often mention that having a dedicated translator makes the medical process stress-free. Many highlight the relief of moving from arrival to surgery in just a few days.
Turkish oncology centers utilize advanced surgical and systemic therapies for kidney cancer. Primary treatments include da Vinci robotic-assisted nephrectomy and laparoscopic surgery. Patients also access innovative targeted therapy and immunotherapy. High-precision radiation and CyberKnife technologies are standard for complex metastatic cases.
Bookimed Expert Insight: Anadolu Medical Center stands out because it is affiliated with Johns Hopkins Medicine. This brings American oncology protocols to Istanbul at a lower cost. Their multidisciplinary team approach ensures that surgeons and oncologists review every case together. This collaboration often leads to 15% better outcomes in complex cases. Some clinics also offer genomic profiling to tailor drug regimens.
Patient Consensus: Patients often mention the speed of starting treatment after their first arrival. They note that having translators and transfers included helps them focus on recovery.
Turkey reports a 90% to 94% 5-year survival rate for localized kidney cancer. Specialized centers achieve up to 100% technical success using cryotherapy for small tumors. Turkish facilities utilize the Da Vinci robotic system to maintain 95% surgical success rates for partial nephrectomies.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center or Medipol often perform over 65,000 yearly operations. This massive volume allows surgeons to master robot-assisted partial nephrectomies. High-volume practice helps preserve kidney function while ensuring complete tumor removal.
Patient Consensus: Patients value the speed of diagnosis and the professionalism of Turkish medical teams. Many note that robotic options were available much sooner than in their home countries.